Vivos Therapeutics, Inc. (VVOS)
USD 2.61
(1.56%)
USD 2.61
(1.56%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.31 Million USD | 15.7% |
| 2022 | 8.91 Million USD | 9.44% |
| 2021 | 8.15 Million USD | -3.09% |
| 2020 | 8.41 Million USD | -19.86% |
| 2019 | 10.49 Million USD | 210.75% |
| 2018 | 3.37 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 9.49 Million USD | -15.39% |
| 2024 Q1 | 11.22 Million USD | 8.75% |
| 2023 Q1 | 10.1 Million USD | 13.32% |
| 2023 Q2 | 11.64 Million USD | 15.2% |
| 2023 FY | 10.31 Million USD | 15.7% |
| 2023 Q4 | 10.31 Million USD | 0.47% |
| 2023 Q3 | 10.27 Million USD | -11.78% |
| 2022 Q1 | 8.7 Million USD | 6.76% |
| 2022 FY | 8.91 Million USD | 9.44% |
| 2022 Q4 | 8.91 Million USD | 4.38% |
| 2022 Q3 | 8.54 Million USD | -10.39% |
| 2022 Q2 | 9.53 Million USD | 9.6% |
| 2021 Q2 | 9.67 Million USD | 27.05% |
| 2021 FY | 8.15 Million USD | -3.09% |
| 2021 Q4 | 8.15 Million USD | -4.73% |
| 2021 Q3 | 8.55 Million USD | -11.56% |
| 2021 Q1 | 7.61 Million USD | -9.47% |
| 2020 FY | 8.41 Million USD | -19.86% |
| 2020 Q3 | 10.41 Million USD | 14.4% |
| 2020 Q2 | 9.1 Million USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 8.41 Million USD | -19.21% |
| 2019 Q4 | 10.49 Million USD | 0.0% |
| 2019 FY | 10.49 Million USD | 210.75% |
| 2018 FY | 3.37 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 79.867% |
| BrainsWay Ltd. | 15.31 Million USD | 32.617% |
| Cerus Corporation | 144.3 Million USD | 92.849% |
| Envoy Medical, Inc. | 9.4 Million USD | -9.753% |
| electroCore, Inc. | 8.94 Million USD | -15.361% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -93.167% |
| IceCure Medical Ltd | 4.24 Million USD | -142.972% |
| Inogen, Inc. | 121.38 Million USD | 91.499% |
| OrthoPediatrics Corp. | 72.56 Million USD | 85.779% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 65.116% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -224.299% |
| MaxCyte, Inc. | 36.1 Million USD | 71.421% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -458.415% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2326.396% |
| Orthofix Medical Inc. | 326.58 Million USD | 96.84% |
| PAVmed Inc | 57.13 Million USD | 81.94% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 59.475% |
| RxSight, Inc. | 22.18 Million USD | 53.493% |
| Sight Sciences, Inc. | 46.43 Million USD | 77.778% |
| SI-BONE, Inc. | 61.05 Million USD | 83.097% |
| TELA Bio, Inc. | 59.16 Million USD | 82.56% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 90.946% |
| Acutus Medical, Inc. | 54.83 Million USD | 81.183% |
| Talis Biomedical Corporation | 29.22 Million USD | 64.69% |
| Spectral AI, Inc. | 12.4 Million USD | 16.789% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 55.395% |
| CVRx, Inc. | 39.28 Million USD | 73.731% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 13.707% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -324.773% |
| Bioventus Inc. | 589.79 Million USD | 98.25% |
| Venus Concept Inc. | 107.1 Million USD | 90.365% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 80.026% |
| LivaNova PLC | 1.15 Billion USD | 99.104% |
| 908 Devices Inc. | 37.49 Million USD | 72.475% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 98.533% |
| Nemaura Medical Inc. | 26.37 Million USD | 60.879% |
| NeuroPace, Inc. | 86.99 Million USD | 88.139% |
| LENSAR, Inc. | 22.4 Million USD | 53.952% |
| Apyx Medical Corporation | 52.31 Million USD | 80.276% |
| Cutera, Inc. | 518.12 Million USD | 98.008% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 64.815% |
| BioSig Technologies, Inc. | 4.68 Million USD | -120.256% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 82.32% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 51.978% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.53% |
| Axonics, Inc. | 82.35 Million USD | 87.471% |
| Outset Medical, Inc. | 190.91 Million USD | 94.595% |
| IRIDEX Corporation | 24.91 Million USD | 58.582% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 91.676% |
| IRadimed Corporation | 20.73 Million USD | 50.236% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -516.428% |
| INVO Bioscience, Inc. | 19.99 Million USD | 48.392% |
| Telesis Bio, Inc. | 40.87 Million USD | 74.754% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 74.702% |
| Varex Imaging Corporation | 668.6 Million USD | 98.457% |
| Quipt Home Medical Corp. | 136.29 Million USD | 92.429% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -188.886% |
| Pulmonx Corporation | 60.63 Million USD | 82.982% |
| Dynatronics Corporation | 11.78 Million USD | 12.403% |
| Modular Medical, Inc. | 2.27 Million USD | -354.181% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -153.912% |
| Semler Scientific, Inc. | 6.27 Million USD | -64.577% |
| InMode Ltd. | 75.91 Million USD | 86.407% |
| Bruker Corporation | 2.83 Billion USD | 99.636% |
| Cytosorbents Corporation | 29.98 Million USD | 65.587% |
| DexCom, Inc. | 4.19 Billion USD | 99.754% |
| Align Technology, Inc. | 2.45 Billion USD | 99.579% |
| Viveve Medical, Inc. | 10.84 Million USD | 4.868% |
| ZimVie Inc. | 795.85 Million USD | 98.703% |
| Movano Inc. | 5.97 Million USD | -72.79% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 90.135% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2326.396% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 13.707% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.385% |
| Profound Medical Corp. | 12.66 Million USD | 18.529% |
| Insulet Corporation | 1.85 Billion USD | 99.444% |
| enVVeno Medical Corporation | 2.43 Million USD | -323.778% |
| Surmodics, Inc. | 65.82 Million USD | 84.323% |
| iCAD, Inc. | 8 Million USD | -28.971% |
| Nuwellis, Inc. | 6.78 Million USD | -52.198% |
| Biotricity, Inc. | 35.91 Million USD | 71.272% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 95.374% |
| Aethlon Medical, Inc. | 2.47 Million USD | -316.147% |
| InspireMD, Inc. | 8.14 Million USD | -26.738% |
| PAVmed Inc. | 57.13 Million USD | 81.94% |
| BIOLASE, Inc. | 35.34 Million USD | 70.807% |
| Beyond Air, Inc. | 29.77 Million USD | 65.343% |
| FONAR Corporation | 57.45 Million USD | 82.041% |
| AxoGen, Inc. | 101.16 Million USD | 89.8% |
| Vivani Medical, Inc. | 25.03 Million USD | 58.783% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 88.247% |
| Inari Medical, Inc. | 209.32 Million USD | 95.07% |
| UFP Technologies, Inc. | 118.04 Million USD | 91.258% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 18.687% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -372.09% |
| Tenon Medical, Inc. | 5.56 Million USD | -85.36% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -480.045% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 41.483% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.673% |
| Sintx Technologies, Inc. | 6.59 Million USD | -56.514% |
| NanoVibronix, Inc. | 2.68 Million USD | -284.177% |
| Quanterix Corporation | 78.08 Million USD | 86.785% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -188.886% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -111.238% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.012% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.186% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 38.143% |
| NeuroMetrix, Inc. | 1.33 Million USD | -674.047% |
| Hyperfine, Inc. | 9.8 Million USD | -5.296% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 95.876% |
| Biomerica, Inc. | 2.66 Million USD | -287.495% |
| Bone Biologics Corporation | 831.4 Thousand USD | -1141.157% |
| AVITA Medical, Inc. | 19.86 Million USD | 48.055% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -422.83% |
| Silk Road Medical, Inc | 114.15 Million USD | 90.961% |